Sun Pharma is set to buy US drugmaker Organon for $12.5 billion, expected to be decided at a board meeting over the weekend. The Mumbai-based company will beat the EQT-Gruenthal consortium, paying $4.5 billion for Organon’s equity while taking on $8.5 billion of debt, with an announcement likely tonight or by Monday.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
